Patent · US Active

3-(5-amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof

US11833142B2 · kind B2 · utility

0Cited by

6References

5Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Rohan Eric John Beckwith · Cambridge, US
Simone BONAZZI · Cambridge, US
Artiom CERNIJENKO · Cambridge, US
Fupeng Ma · Cambridge, US
Nathaniel F. Ware · Medford, US

Key dates

Filing date	Oct 4, 2021
Grant date	Dec 5, 2023
Priority date	—
Expiry date	Oct 4, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D401/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure provides a compound of Formula (I′):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.